Prior to leaving the corporate world in 2005, Jim spent 35 years with companies engaged in healthcare distribution, the last 20 years at President, COO or Senior Vice-President level with full operational and P&L responsibility. Companies or Divisions for which he was responsible ranged in size from start-up to over $2.5 billion.
Since establishing an independent business advisory practice in 2006, Jim has been engaged by clients from three broad categories
Investment banking analysts and portfolio managers seeking insight into the pharmaceutical distribution industry relative to major companies’ strengths and weaknesses, overall marketplace positioning, profitability drivers, etc.
Companies within the pharmaceutical distribution industry for specific project-related strategy development, implementation and execution.
Medium-sized firms within the greater Cincinnati area seeking the benefit of Jim’s broad depth of experience in establishing strategies in a wide spectrum of needs ranging from managing growth, financing requirements, owner exit strategies and mergers and acquisitions.
Jim is also actively involved The Goering Center at the University of Cincinnati College of Business and in the local chapter of SCORE, America's premier source of free and confidential small business advice for entrepreneurs.
EXECUTIVE CAREER PATH
President, Wholesale Operations for the F. Dohmen Company, a family-owned and operated, traditional drug wholesaler, consisting of four distribution centers and annual revenues of $2.5 billion. 2004-2005
President and Chief Operating Officer for Superior Pharmaceutical Company and RxBazaar, a specialty generic pharmaceutical distributor coupled with an Internet-based trading exchange, providing a unique mechanism for linking buyers and sellers of price-advantaged pharmaceutical products. Grew revenues from $15 million to over $100 million. 2000-2004
President, North American Dental Group for Henry Schein, a publicly traded distributor of products and services to office-based healthcare providers throughout the world. The North American Dental Group was the largest of five operating units, contributing more than 50% of worldwide revenues and operating income. Increased group revenues from $260 million to $1.1 billion through a combination of double-digit internal growth and fourteen acquisitions. 1994-2000
Senior Vice-President for FoxMeyer, once the third largest and fastest-growing pharmaceutical distributor in the U.S. 1987-1994
McKesson Drug Co. Prior to 1987